Cheng-Wei Lai1, Hsiao-Ling Chen2, Chih-Ching Yen1,3, Jiun-Long Wang1,4, Shang-Hsun Yang5, Chuan-Mu Chen6,7,8. 1. Department of Life Sciences, National Chung Hsing University, Taichung, 402, Taiwan. 2. Department of Bioresources, Da-Yeh University, Changhua, 515, Taiwan. 3. Department of Internal Medicine, China Medical University Hospital, Taichung, 404, Taiwan. 4. Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 407, Taiwan. 5. Department of Physiology, and Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, 701, Taiwan. 6. Department of Life Sciences, National Chung Hsing University, Taichung, 402, Taiwan. chchen1@dragon.nchu.edu.tw. 7. Rong-Hsing Translational Medicine Center, iEGG Center, National Chung Hsing University, Taichung, 402, Taiwan. chchen1@dragon.nchu.edu.tw. 8. Agricultural Biotechnology Center, National Chung Hsing University, No. 250, Kuo Kuang Rd., Taichung, 402, Taiwan. chchen1@dragon.nchu.edu.tw.
Abstract
PURPOSE: Lung adenocarcinoma is characterized by a poor prognosis and high mortality worldwide. In this study, we purposed to use the live imaging techniques and a reporter gene that generates highly penetrative near-infrared (NIR) fluorescence to establish a preclinical animal model that allows in vivo monitoring of lung cancer development and provides a non-invasive tool for the research on lung cancer pathogenesis and therapeutic efficacy. PROCEDURES: A human lung adenocarcinoma cell line (A549), which stably expressed the dual fluorescence reporting gene (pCAG-iRFP-2A-Venus), was used to generate subcutaneous or orthotopic lung cancer in nude mice. Cancer development was evaluated by live imaging via the NIR fluorescent signals from iRFP, and the signals were verified ex vivo by the green fluorescence of Venus from the gross lung. The tumor-bearing mice received miR-16 nucleic acid therapy by intranasal administration to demonstrate therapeutic efficacy in this live imaging system. RESULTS: For the subcutaneous xenografts, the detection of iRFP fluorescent signals revealed delicate changes occurring during tumor growth that are not distinguishable by conventional methods of tumor measurement. For the orthotopic xenografts, the positive correlation between the in vivo iRFP signal from mice chests and the ex vivo green fluorescent signal from gross lung tumors and the results of the suppressed tumorigenesis by miR-16 treatment indicated that lung tumor size can be accurately quantified by the emission of NIR fluorescence. In addition, orthotopic lung tumor localization can be accurately visualized using iRFP fluorescence tomography in vivo, thus revealing the trafficking of lung tumor cells. CONCLUSIONS: We introduced a novel dual fluorescence lung cancer model that provides a non-invasive option for preclinical research via the use of NIR fluorescence in live imaging of lung.
PURPOSE:Lung adenocarcinoma is characterized by a poor prognosis and high mortality worldwide. In this study, we purposed to use the live imaging techniques and a reporter gene that generates highly penetrative near-infrared (NIR) fluorescence to establish a preclinical animal model that allows in vivo monitoring of lung cancer development and provides a non-invasive tool for the research on lung cancer pathogenesis and therapeutic efficacy. PROCEDURES: A humanlung adenocarcinoma cell line (A549), which stably expressed the dual fluorescence reporting gene (pCAG-iRFP-2A-Venus), was used to generate subcutaneous or orthotopic lung cancer in nude mice. Cancer development was evaluated by live imaging via the NIR fluorescent signals from iRFP, and the signals were verified ex vivo by the green fluorescence of Venus from the gross lung. The tumor-bearing mice received miR-16 nucleic acid therapy by intranasal administration to demonstrate therapeutic efficacy in this live imaging system. RESULTS: For the subcutaneous xenografts, the detection of iRFP fluorescent signals revealed delicate changes occurring during tumor growth that are not distinguishable by conventional methods of tumor measurement. For the orthotopic xenografts, the positive correlation between the in vivo iRFP signal from mice chests and the ex vivo green fluorescent signal from gross lung tumors and the results of the suppressed tumorigenesis by miR-16 treatment indicated that lung tumor size can be accurately quantified by the emission of NIR fluorescence. In addition, orthotopic lung tumor localization can be accurately visualized using iRFP fluorescence tomography in vivo, thus revealing the trafficking of lung tumor cells. CONCLUSIONS: We introduced a novel dual fluorescence lung cancer model that provides a non-invasive option for preclinical research via the use of NIR fluorescence in live imaging of lung.
Entities:
Keywords:
Live imaging; NSCLC; Near-infrared fluorescence; Orthotopic xenograft; iRFP
Authors: Xiaokun Shu; Antoine Royant; Michael Z Lin; Todd A Aguilera; Varda Lev-Ram; Paul A Steinbach; Roger Y Tsien Journal: Science Date: 2009-05-08 Impact factor: 47.728
Authors: Kenneth M Tichauer; Robert W Holt; Kimberley S Samkoe; Fadi El-Ghussein; Jason R Gunn; Michael Jermyn; Hamid Dehghani; Frederic Leblond; Brian W Pogue Journal: J Vis Exp Date: 2012-07-17 Impact factor: 1.355
Authors: Daria M Shcherbakova; Olesya V Stepanenko; Konstantin K Turoverov; Vladislav V Verkhusha Journal: Trends Biotechnol Date: 2018-07-23 Impact factor: 19.536
Authors: Shane M Hickey; Ben Ung; Christie Bader; Robert Brooks; Joanna Lazniewska; Ian R D Johnson; Alexandra Sorvina; Jessica Logan; Carmela Martini; Courtney R Moore; Litsa Karageorgos; Martin J Sweetman; Douglas A Brooks Journal: Cells Date: 2021-12-23 Impact factor: 6.600